ARPC1B种系突变患者的T细胞缺陷导致联合免疫缺陷
该研究在6例早发严重感染、自身免疫表现和血小板减少的无关患者中鉴定出ARPC1B双等位基因突变,发现患者T细胞存在T细胞受体刺激下肌动蛋白丰富片状伪足伸展和免疫突触组装障碍,并伴有T细胞受体介导的增殖和SDF1-α定向迁移受损,提示ARPC1B缺陷通过改变T细胞细胞骨架动力学和功能导致联合免疫缺陷。
要点
- ARPC1B双等位基因突变患者表现为早发严重感染、自身免疫表现和血小板减少。
- 患者T细胞在T细胞受体刺激下无法伸展肌动蛋白丰富片状伪足和组装免疫突触。
- 慢病毒载体基因转移可恢复患者T细胞ARPC1B表达和体外增殖。
核心结论
- 遗传性ARPC1B缺陷改变T细胞细胞骨架动力学和功能,导致联合免疫缺陷的临床特征。
研究设计与样本
- 研究纳入6例无关的早发疾病患者,鉴定ARPC1B双等位基因突变并进行免疫功能、细胞骨架和基因转移研究。
主要发现
- 6例无关患者具有早发疾病,特征为严重感染、自身免疫表现和血小板减少。
- 免疫学特征包括T细胞淋巴细胞减少、初始T细胞数量低和高免疫球蛋白E。
- ARPC1B蛋白结构改变导致流式细胞术和共聚焦显微镜下表达缺失或降低。
- 患者来源T细胞在T细胞受体刺激下不能伸展肌动蛋白丰富片状伪足和组装免疫突触。
- ARPC1B缺陷T细胞显示T细胞受体介导的增殖和SDF1-α定向迁移受损。
关键数值与推荐
- 使用慢病毒载体将ARPC1B基因转移至患者T细胞,在体外恢复ARPC1B表达和T细胞增殖。
- 2例患者体内体细胞回复在一部分淋巴细胞中恢复ARPC1B表达,并与T细胞受体库偏斜相关。
- 1例回复患者中表达正常水平ARPC1B的记忆CD8+ T细胞显示T细胞迁移改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ARPC1B is a key factor for the assembly and maintenance of the ARP2/3 complex that is involved in actin branching from an existing filament. Germline biallelic mutations in ARPC1B have been recently described in 6 patients with clinical features of combined immunodeficiency (CID), whose neutrophils and platelets but not T lymphocytes were studied. We hypothesized that ARPC1B deficiency may also lead to cytoskeleton and functional defects in T cells. We have identified biallelic mutations in ARPC1B in 6 unrelated patients with early onset disease characterized by severe infections, autoimmune manifestations, and thrombocytopenia. Immunological features included T-cell lymphopenia, low numbers of naïve T cells, and hyper-immunoglobulin E. Alteration in ARPC1B protein structure led to absent/low expression by flow cytometry and confocal microscopy. This molecular defect was associated with the inability of patient-derived T cells to extend an actin-rich lamellipodia upon T-cell receptor (TCR) stimulation and to assemble an immunological synapse. ARPC1B-deficient T cells additionally displayed impaired TCR-mediated proliferation and SDF1-α-directed migration. Gene transfer of ARPC1B in patients' T cells using a lentiviral vector restored both ARPC1B expression and T-cell proliferation in vitro. In 2 of the patients, in vivo somatic reversion restored ARPC1B expression in a fraction of lymphocytes and was associated with a skewed TCR repertoire. In 1 revertant patient, memory CD8+ T cells expressing normal levels of ARPC1B displayed improved T-cell migration. Inherited ARPC1B deficiency therefore alters T-cell cytoskeletal dynamics and functions, contributing to the clinical features of CID.
引用
- Brigida I, Zoccolillo M, Cicalese MP, et al. T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency. Blood. 2018. PMID: 30254128. doi:10.1182/blood-2018-07-863431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。